Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
VIDEO from Merck and Co., Inc available on thenewsmarket.com: In Phase III Study Merck's Investigational CETP Inhibitor Anacetrapib Met Safety and Efficacy Endpoints in Patients with CHD
Date:11/17/2010
NEW YORK, Nov. 17, 2010 /PRNewswire/ -- See video from Merck and Co., Inc at:
Researchers today presented results from the Phase III DEFINE (Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib) study with Merck's investigational CETP inhibitor, anacetrapib. In the trial of 1,623 patients with coronary heart disease (CHD) or CHD risk equivalents, anacetrapib showed no significant differences from placebo in the primary safety measures studied. There were no significant differences in mean changes in blood pressure between the anacetrapib and placebo treatment groups, nor were there any significant differences in serum electrolytes or aldosterone levels. During the 76-week treatment phase, the pre-specified adjudicated cardiovascular endpoint (defined as cardiovascular death, myocardial infarction, unstable angina or stroke) occurred in 16 anacetrapib-treated patients (2.0 percent) compared with 21 placebo-treated patients (2.6 percent) (p=0.40). At 24 weeks, anacetrapib decreased LDL-C by 40 percent (from 81 to 45 mg/dl vs. 82 to 77 mg/dl for placebo, p<0.001) and increased HDL-C by 138 percent (from 40 to 101 mg/dl vs. 40 to 46 mg/dl for placebo, p<0.001) in patients already treated with a statin and at guideline-recommended LDL-C goal. The DEFINE data were presented today at the American Heart Association Scientific Sessions and published concurrently online in the New England Journal of Medicine. Available content includes soundbites and b-roll.
About thenewsmarket.com
thenewsmarket.com delivers free broadcast- and streaming-quality video and multimedia con
'/>"/>
| SOURCE thenewsmarket.com Copyright©2010 PR Newswire. All rights reserved |
Related medicine technology :
1. VIDEO from International Osteoporosis Foundation available on thenewsmarket.com: IOF Focuses on WHO Fracture Risk Assessment Tool for International Discussions
2. Shrink Nanotechnologies Unveils Videos of StemDisc450 Prototype Growing Human Embryonic Stem Cells
3. VIDEO From thenewsmarket.com and Lundbeck: Lundbeck Continues Strong Growth in Third Quarter
4. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
5. VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
6. VIDEO From thenewsmarket.com and AstraZeneca: AstraZeneca Announces Third Quarter and Nine Months Results 2010
7. VIDEO From thenewsmarket.com and Novartis: Phase III Data Show That Novartis Meningococcal Vaccine Menveo® Demonstrated Robust Immunogenicity in Infants
8. Generex Reschedules Live Video Webcast
9. Aircraft Medical Launches Worlds First Low Cost Video Laryngoscope
10. New Manhattan Research Report Explores the Growing Consumer Demand for Online Health Video and How Pharma Marketers Can Leverage this Format
11. New Study: Physician Adoption of Live Video Detailing Has Doubled Since 2008, But Will Likely Plateau Until 2012 as Pharma Optimizes Targeting
Post Your Comments:
(Date:1/15/2014)... , January 15, 2014 Shire plc ... has waived the Office of Fair Trading (OFT) approval condition ... shares of ViroPharma Incorporated (NASDAQ: VPHM). As ... conditional on OFT approval, and Shire expects to complete the ... expiration time, subject to the satisfaction of all of the ...
(Date:1/15/2014)... 15, 2014 Manufacturers, suppliers and distributors ... be able to protect their most important ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) ... Medical Device Industry, it steadfastly remains one ... cases involving IP infringement. This litigious nature ...
(Date:1/15/2014)... WOONSOCKET, R.I. , Jan. 15, 2014 ... ) has filed a U.S. provisional patent application concerning ... and formulations to achieve targeted tumor cell death. ... of very small noncoding double stranded RNA molecules (VSRNAs) ... tumor cells. VSRNAs are of molecular size less than ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3... Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global ... Orthopaedic Association (COA) International Congress that the Company will ... China. The center will lay the foundation for a ... "The Asia-Pacific region offers significant growth opportunities ...
... Corporation (Nasdaq: KEQU ) today announced the financial ... Sales for the quarter were $25,962,000, up 1.3% over ... net loss of $125,000, or $0.05 per diluted share, was ... $855,000, or $0.33 per diluted share, in the second quarter ...
Cached Medicine Technology:Zimmer to Establish Asia-Pacific Research and Development Center 2Kewaunee Scientific Announces Results for Second Quarter 2Kewaunee Scientific Announces Results for Second Quarter 3Kewaunee Scientific Announces Results for Second Quarter 4Kewaunee Scientific Announces Results for Second Quarter 5Kewaunee Scientific Announces Results for Second Quarter 6(Date:3/14/2014)... (GW) researchers report dramatic increases in prescriptions of ... Dilaudid, during U.S. emergency department visits from 2001 ... higher visit rates for painful conditions, which only ... was published today in the journal Academic ... concerning given dramatic increases in opioid-related overdoses and ...
(Date:3/14/2014)... Leading SAGE medical journal, Menopause International , ... expanding its scope and changing its name to Post ... Health is a MEDLINE indexed, peer reviewed, source of ... in the field of Post Reproductive Health study ... practitioners and researchers. As the official journal of BMS, ...
(Date:3/14/2014)... Patient requests for specific medicationsincluding requests for brand-name ... on doctors, prescribing decisions, suggests a study in the ... The journal is published by Lippincott Williams ... Health . , "A patient request for a specific ... prescribe that medication," according to the new research led ...
(Date:3/14/2014)... - A technique called distraction osteogenesis can create increased length ... palate deformities, reports a study in the March issue of ... by Mutaz B. Habal, MD, published by Lippincott Williams ... . , Distraction Technique Used to Lengthen the Palate ... and colleagues, report on the use of distraction osteogenesis to ...
(Date:3/14/2014)... "Imitation is not just the sincerest form of flattery ... psychologists, imitation is something that we all do whenever ... or how to behave in specific social situations. , ... a team of neuroscientists at Vanderbilt University strengthen the ... the profound and enduring difficulty with social interactions that ...
Breaking Medicine News(10 mins):Health News:Researchers find significant increase in painkillers prescribed to US adults in the ER 2Health News:Menopause International re-launching as Post Reproductive Health 2Health News:Patient requests for specific drugs have major impact on prescribing, reports study in Medical Care 2Health News:Patient requests for specific drugs have major impact on prescribing, reports study in Medical Care 3Health News:Bone lengthening technique proves useful in patients with cleft palate 2Health News:Brain mapping confirms patients with schizophrenia have impaired ability to imitate 2Health News:Brain mapping confirms patients with schizophrenia have impaired ability to imitate 3Health News:Brain mapping confirms patients with schizophrenia have impaired ability to imitate 4[0] Researchers find significant increase in painkillers prescribed to US adults in the ER[0] Menopause International re-launching as Post Reproductive Health[0] Patient requests for specific drugs have major impact on prescribing, reports study in Medical Care[0] Bone lengthening technique proves useful in patients with cleft palate[0] Brain mapping confirms patients with schizophrenia have impaired ability to imitate
... greater online collaboration ... between physicians and patients, CHICAGO, Oct. 4 ... software, connectivity and information,solutions that physicians use to improve healthcare, ... DC press,conference announcing the new consumer health platform. Allscripts is ...
... Fire Response up 10% in Six Years, WASHINGTON, Oct. ... and take action to prevent home fires during,National Fire Prevention ... not only the most common disaster that the Red Cross,responds ... home,fires the Red Cross responds to is up 10 percent ...
... accreditation developed for the industry, PHILADELPHIA, ... management division, announced today that it is ... URAC,s new Pharmacy Benefit,Management Standards. Nearly ... medications,through pharmacy benefit management companies. URAC accreditation ...
... ROCHESTER, Minn. -- Although medication can help extend the lives ... this disease can interfere with a persons ability to engage ... and the fear of damaging the heart can cause people ... wonder whether this activity is safe for them. , ...
... Athens, Ga. - A 1998 settlement designed to limit the ... to a new University of Georgia study published in the ... , Exposure rates are significant and have been very ... Krugman, professor in the UGA Grady College of Journalism and ...
... ),announced today that its Vice Chairman and CEO Robert ... the New York Stock Exchange (NYSE) at 4 p.m.,today, ... acquisition,of Merck Generics. Mylan announced on Tuesday, October 2, ... business to become one,of the largest quality generics and ...
Cached Medicine News:Health News:Allscripts Featured in Microsoft HealthVault Worldwide Launch 2Health News:Allscripts Featured in Microsoft HealthVault Worldwide Launch 3Health News:Allscripts Featured in Microsoft HealthVault Worldwide Launch 4Health News:Allscripts Featured in Microsoft HealthVault Worldwide Launch 5Health News:Allscripts Featured in Microsoft HealthVault Worldwide Launch 6Health News:American Red Cross Stresses Family Preparedness During National Fire Prevention Week, Oct. 7-13 2Health News:PerformRx Earns New URAC Accreditation for Pharmacy Benefit Management 2Health News:Mayo Clinic Proceedings: Men with chronic heart failure can have active sex lives 2Health News:Mayo Clinic Proceedings: Men with chronic heart failure can have active sex lives 3Health News:UGA study: Youth exposed to smokeless tobacco ads despite settlement 2Health News:UGA study: Youth exposed to smokeless tobacco ads despite settlement 3Allscripts Featured in Microsoft HealthVault Worldwide LaunchAmerican Red Cross Stresses Family Preparedness During National Fire Prevention Week, Oct. 7-13PerformRx Earns New URAC Accreditation for Pharmacy Benefit ManagementMayo Clinic Proceedings: Men with chronic heart failure can have active sex livesUGA study: Youth exposed to smokeless tobacco ads despite settlementMylan Vice Chairman and CEO Robert J. Coury to Ring NYSE Closing Bell(R) in Celebration of Merck Generics Acquisition
Double Ended Occluders...
Double Ended Occluders...
Long handle occluders are approximately 9 inches long....
Basic external reading model....
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |